← Back to Search

Insulin

Lyumjev for Type 1 Diabetes

Phase 1
Waitlist Available
Research Sponsored by Eli Lilly and Company
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up predose up to 240 minutes postdose
Awards & highlights

Study Summary

This trial will compare the effects of two different insulin treatments on blood sugar levels during exercise in people with type 1 diabetes. It will last up to 10 weeks and include up to 7 visits.

Eligible Conditions
  • Type 1 Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~predose up to 240 minutes postdose
This trial's timeline: 3 weeks for screening, Varies for treatment, and predose up to 240 minutes postdose for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change From Baseline in Plasma Glucose (PG) From the Start to the End of Exercise for Each Treatment Arm
Secondary outcome measures
Change From Baseline in Postprandial Plasma Glucose (PPG) Excursion During Mixed-Meal Tolerance Test (MMTT) for Each Treatment Arm

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: LyumjevExperimental Treatment1 Intervention
Lyumjev administered subcutaneously (SC) during a meal and following different approaches for basal reduction prior to exercise
Group II: HumalogActive Control1 Intervention
Humalog administered SC during a meal and following different approaches for basal reduction prior to exercise
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Lyumjev
2022
Completed Phase 1
~30

Find a Location

Who is running the clinical trial?

Eli Lilly and CompanyLead Sponsor
2,615 Previous Clinical Trials
3,201,033 Total Patients Enrolled
Study DirectorEli Lilly and Company
1,344 Previous Clinical Trials
405,227 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals aged 50 and above eligible to join this clinical trial?

"This trial stipulates that the minimum age of enrollment is 18 and the maximum age is 55."

Answered by AI

Is Lyumjev a reliable source of treatment for patients?

"Our team assessed Lyumjev's safety to be a 1, as the clinical trial is currently in its initial stage and has limited data for efficacy and safety."

Answered by AI

What is the scope of enrolment to this research project?

"Affirmative. Clinicaltrials.gov records demonstrate that this clinical trial is actively seeking participants, having been initially posted on February 14th 2022 and most recently updated on September 9th 2022. 32 patients are required to be recruited at one medical facility."

Answered by AI

Are there any vacancies for participants in this medical experiment?

"Affirmative. Based on information available from clinicaltrials.gov, this medical trial is actively seeking out volunteers to participate and began recruiting participants as of February 14th 2022. The study is looking for a total of 32 individuals across 1 site and was last updated on September 9th 2022."

Answered by AI

Is it possible to participate in this investigation?

"32 patients are sought for this trial. To be eligible, applicants must have diabetes and an autoimmune disorder in addition to being between 18-55 years of age."

Answered by AI

Who else is applying?

How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
What state do they live in?
New Jersey
South Carolina
New York
How many prior treatments have patients received?
3+
Recent research and studies
clinicaltrials.govStudy
A Study of LY900014 (Lyumjev) Versus Insulin Lispro (Humalog) in Participants With Type 1 Diabetes
2022. "A Study of LY900014 (Lyumjev) Versus Insulin Lispro (Humalog) in Participants With Type 1 Diabetes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05262387.
~8 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top